A

Agilent Technologies
Life Sciences Tools & Services · Health Care · as of 2026-08-19
Last close
$155.41
+4.7% on the session
1-year return
+32.6%
+22.9% over six months
Volatility
33.1%
annualized, trailing year
Max drawdown
-29.7%
worst peak to trough, 1y
What the numbers say

Agilent Technologies is a life sciences tools & services name in the health care sector. Over the past year it returned +32.6%, against +40.8% over three months and +17.0% over one. It trades 18.8% above its 200-day average, so the longer trend is confirming recent strength. Annualized volatility of 33.1% is above the market's typical range.

Its worst peak-to-trough decline over the year was -29.7%, and it has traded a median $276M a day — the figure that decides whether a position can actually be entered and exited at posted prices. Its daily moves correlate 0.34 with the S&P 500 proxy, so it has been moving substantially on its own.

Where it ranks
Within Health Care#24 of 59
Stronger than 60% of its sector on the momentum profile
Across the whole index#43 of 500

How A scores on all four profiles

Its standing on steadiness, defensiveness and rebound — plus the factor-by-factor breakdown behind each score, and its closest and least-correlated peers among 7 others in Life Sciences Tools & Services.

Start a free 7-day trial
Full metrics
1 day+4.7%
1 week+4.8%
1 month+17.0%
3 months+40.8%
6 months+22.9%
1 year+32.6%
12-1 momentum+13.4%
Volatility (1y, annualized)33.1%
Max drawdown (1y)-29.7%
Distance vs 200-day average+18.8%
Return per unit of risk0.99
Median daily dollar volume$276M
Free newsletter

Get A when it shows up in a ranking

Two editions a weekday, free — ranked lists built from this same data, on whatever the market is talking about.

Everything on this page is computed from daily adjusted closing prices. It contains no earnings, balance-sheet, guidance or ownership data, and it is not a valuation. Nothing here is tailored to your circumstances or a recommendation to buy or sell. Past performance does not predict future results.